An 85-year-old, female patient presented to the emergency department with a seven-day history of progressive fatigue. She had received a diagnosis of breast cancer two years earlier and was receiving outpatient chemotherapy. She had no valvular prostheses. Physical examination revealed pallor, jaundice, and cachexia with no neurological abnormalities. Laboratory tests revealed hemoglobin 6.1 g/dL (reference range: 11.3-14.7), a normal platelet count, normal prothrombin time and activated partial thromboplastin time, hyperbilirubinemia, lactate dehydrogenase 1707 IU/L (reference range: 115-245), undetectable haptoglobin, and negative direct Coombs’ test. A peripheral blood smear revealed marked schistocytosis including helmet cells (Figure A , red arrows) and other fragmented red cells (Figure A, blue arrows). Platelets were normal (Figure A, dashed arrows). Bone marrow aspiration and a biopsy revealed the presence of tumor cells (Figure B) indicative of bone marrow carcinomatosis. A subsequent ADAMTS13 assay indicated 40% activity, ruling out thrombotic thrombocytopenic purpura (TTP). Based on these findings, cancer-related microangiopathic hemolytic anemia (CR-MAHA) was diagnosed. After a discussion with the oncology team, we concluded that her breast cancer was unlikely to respond to further chemotherapy. She was discharged home with palliative care and died 11 days after the diagnosis.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of the Medical Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature review.Springerplus. 2016; 5: 684
- Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases.Medicine (Baltimore). 2012; 91: 195-205
- Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.Oncology (Williston Park). 2011; 25: 908-914
Published online: May 16, 2022
Accepted: February 11, 2022
Received: May 28, 2021
© 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.